Home » Topics » BioWorld Science

BioWorld Science
RSS

Drug discovery agreement forged by Procept, Abbott

Aug. 18, 1997

Onyx, W-L collaborate on antiinflammatory and immunomodulating agents

Aug. 18, 1997

Patents for collagen markers issued to Ostex

Aug. 18, 1997

New treatment for osteoarthritis approved for marketing in U.S.

Aug. 18, 1997

VEGF RTK inhibitors in the pipeline at Zeneca

Aug. 18, 1997

Clinical trial results announced for novel incontinence therapeutic

Aug. 18, 1997

GalaGen starts Diffistat-G phase II trial

Aug. 18, 1997

Twinrix now available for pediatric use

Aug. 18, 1997

Novo Nordisk: 1997 half-year highlights

Aug. 18, 1997

Phenobarbital ineffective in stopping brain bleeding in neonates

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....